ConductScience.org, home

Gene · 962

CD48: CD48 molecule

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. CD48: CD48 molecule. Genes, record 962. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/962

On this page

Gene

Symbol
CD48
HGNC
Name
CD48 molecule
HGNC
NCBI Gene ID
962
NCBI Gene
HGNC ID
HGNC:1683
HGNC
Ensembl
ENSG00000117091
NCBI Gene
Aliases
BCM1, BLAST, BLAST1, MEM-102, SLAMF2, hCD48, mCD48
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P09326CD48 antigen2431Ensembl, GeneID, HGNC

Source UniProt

Patents97

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1440579P09326Espacenet
JP 2025183333 A2025-12-1677P09326Espacenet
EP 4650780 A22025-11-198356P09326Espacenet
WO 2025235604 A12025-11-13282P09326Espacenet
WO 2025235605 A12025-11-13282P09326Espacenet
EP 4641201 A22025-10-298536P09326Espacenet
JP 2025147176 A2025-10-062367P09326Espacenet
JP 2025147176 A2025-10-0617028P09326Espacenet
EP 4619424 A22025-09-2432P09326Espacenet
JP 2025529142 A2025-09-04821P09326Espacenet

1 to 10 of 97

See all 97 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants2,184

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleCD48 papersNewest fiscal year
P30CA008748Cancer Center Support Grant272025
P30CA016672Cancer Center Support Grant122025
P30DK043351Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital102025
P30CA016058Cancer Center Support Grant92025
P30CA013330Cancer Center Support Grant82025
P01CA066996Development of Novel Therapeutic Strategies in Human Leukemias72025
P30CA021765Cancer Center Support Grant (CCSG)72025
P30AI050410The University of North Carolina Center for AIDS Research62025
P30CA006927Comprehensive Cancer Center Program at Fox Chase62025
P30CA016087Cancer Center Support Grant62025

1 to 10 of 2,184Source NIH's project files

See all 2,184 nih grants

Papers3,378

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Integrative Omics Analysis Reveals a CD206+ Macrophage/Dendritic Cell-CD155-TIGIT+ Regulatory T Cell Axis as a Protective Immune Checkpoint Pathway in Atherosclerosis Progression.Barrier Immun202642819567PubTator, text miningPubMed
Radiation-induced SLAMF1 reconfigures the SLAM family receptors landscape in triple-negative breast cancer cells.J Cancer202642807708PubTator, text miningPubMed
Alternative splicing of CD244 restrains natural killer cells at the maternal-fetal interface.Mucosal Immunol202642805341PubTator, text miningPubMed
Dual targeting of CD244 and CD2 by a viral-immunoevasin-guided engineered CD48-Fc mutant for T- and NK-cell modulation.Front Immunol202642746293PubTator, text miningPubMed
Role of spin-orbit and nuclear motion assisted spin-orbit coupling on the structural isomerism dependent intersystem crossing mechanism.J Chem Phys202642635283PubTator, text miningPubMed
Irradiated CD19 chimeric antigen receptor YTS cells retain antitumor activity and offer a scalable alternative to autologous CAR-T therapy.Haematologica202642610426PubTator, text miningPubMed
CD48 and CXCR4 as immune-associated biomarkers in periodontitis: an integrative analysis and validation study.Front Immunol202642465757PubTator, text miningPubMed
CD48 expression in T-lymphoblastic leukemia/lymphoma and mature T-cell neoplasms: role in detecting measurable residual disease and potential confounders, a single-institution retrospective review.Am J Clin Pathol202642269000PubTator, text miningPubMed
Exploring the gut-lung axis in post-liver transplant acute lung injury: A multi-omics approach.Acta Microbiol Immunol Hung202642258310PubTator, text miningPubMed
Extending structural surfaceomics to identify aberrant conformations of tumor surface proteins as potential immunotherapy targets.bioRxiv202642239335PubTator, text miningPubMed

1 to 10 of 3,378

See all 3,378 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/962

GET https://conductscience.org/api/genes/v1/962/patents?page=2